MP04-16 THULIUM YAG VS THULIUM FIBER LASER ENUCLEATION OF THE PROSTATE (THULEP VS TFLEP): A MULTI-INSTITUTION TRIAL TO COMPARE INTRA AND EARLY POSTOPERATIVE OUTCOMES

Abstract

You have accessJournal of UrologyCME1 May 2022MP04-16 THULIUM YAG VS THULIUM FIBER LASER ENUCLEATION OF THE PROSTATE (THULEP VS TFLEP): A MULTI-INSTITUTION TRIAL TO COMPARE INTRA AND EARLY POSTOPERATIVE OUTCOMES Matteo Maltagliati, Lorenzo Berti, Salvatore Micali, Umberto Besana, Carlo Buizza, Bernardo Rocco, Maria Chiara Sighinolfi, Andrea Pacchetti, Jean Baptiste Roche, and Giorgio Bozzini Matteo MaltagliatiMatteo Maltagliati More articles by this author , Lorenzo BertiLorenzo Berti More articles by this author , Salvatore MicaliSalvatore Micali More articles by this author , Umberto BesanaUmberto Besana More articles by this author , Carlo BuizzaCarlo Buizza More articles by this author , Bernardo RoccoBernardo Rocco More articles by this author , Maria Chiara SighinolfiMaria Chiara Sighinolfi More articles by this author , Andrea PacchettiAndrea Pacchetti More articles by this author , Jean Baptiste RocheJean Baptiste Roche More articles by this author , and Giorgio BozziniGiorgio Bozzini More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002521.16AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: To compare clinical intra and early postoperative outcomes between Thulium laser Enucleation of the Prostate (ThuLEP) and Thulium Fiber Laser Enucleation of the Prostate (TFLEP) in the treatment of benign prostatic hyperplasia (BPH). METHODS: 240 patients suffering from lower urinary tract symptoms due to BPH were consecutively enrolled and randomized to either BPH to ThuLEP (n=117) or TFLEP (n=123). Patients were evaluated preoperatively using the International Prostate Symptom Score (IPSS), Quality of Life score (QoL), maximum flow rate (Qmax), and postvoid residual urine volume (PVR). Preoperative prostate volume, PSA and haemoglobin were also recorded. All the patients were evaluated postoperatively with regards to blood loss, catheterization time, irrigation volume, hospital stay and operative time. 3 months after surgery micturition improvement was evaluated using the IPSS, Qmax and PVR. RESULTS: No significant differences were found between the patients in the two study arms. Compared with TFLEP, ThuLEP determined a shorter operative time (63.69 ± 41.44 vs 79.66 ± 48.70 minutes, p=0.045). No significant differences were found between ThuLEP and TFLEP in terms of haemoglobin decrease (0.45 vs 0.47 g/dl, p=0.32), catheterization time (1.9 vs 2.1 days, p=0.37), irrigation volume (29.4 vs 32.8 l, p=0.43), and hospital stay (2.2 vs 2.6 days, p=0.22). During the 3 months of follow-up, the procedures did not demonstrate significant differences in Qmax, IPSS, PVR, and QoL. CONCLUSIONS: ThuLEP and TFLEP both relieve lower urinary tract symptoms equally, with high efficacy and safety. ThuLEP was statistically superior to TFLEP in terms of duration of the procedure. Catheterization time, irrigation volume, hospital stay and operative time were comparable. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e64 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Matteo Maltagliati More articles by this author Lorenzo Berti More articles by this author Salvatore Micali More articles by this author Umberto Besana More articles by this author Carlo Buizza More articles by this author Bernardo Rocco More articles by this author Maria Chiara Sighinolfi More articles by this author Andrea Pacchetti More articles by this author Jean Baptiste Roche More articles by this author Giorgio Bozzini More articles by this author Expand All Advertisement PDF DownloadLoading ...